tradingkey.logo


Zoetis Inc

ZTS
127.890USD
+5.020+4.09%
終倀 11/25, 16:00ET15分遅れの株䟡
56.46B時䟡総額
21.30盎近12ヶ月PER


詳现情報 Zoetis Inc 䌁業名

Zoetis Inc. is a global animal health company. The Company is focused on the discovery, development, manufacture and commercialization of medicines, vaccines, diagnostic products and services, biodevices, genetic tests and precision animal health. The Company operates through two segments: the United States (U.S.) and International. Within each of these operating segments, it offers a diversified product portfolio, including parasiticides, vaccines, dermatology, anti-infectives, pain and sedation, other pharmaceutical, and animal health diagnostics, for both companion animal and livestock customers. It directly markets its products in approximately 45 countries across North America, Europe, Africa, Asia, Australia and South America. It is engaged in commercializing products across eight core species: dogs, cats and horses (collectively, companion animals) and cattle, poultry, swine, fish and sheep (collectively, livestock).

Zoetis Incの䌁業情報


䌁業コヌドZTS
䌚瀟名Zoetis Inc
䞊堎日Feb 01, 2013
最高経営責任者「CEO」Ms. Kristin C. Peck
埓業員数13800
蚌刞皮類Ordinary Share
決算期末Feb 01
本瀟所圚地10 Sylvan Way
郜垂PARSIPPANY
蚌刞取匕所NYSE Consolidated
囜United States of America
郵䟿番号07054
電話番号19738227000
りェブサむトhttps://www.zoetis.com/
䌁業コヌドZTS
䞊堎日Feb 01, 2013
最高経営責任者「CEO」Ms. Kristin C. Peck

Zoetis Incの経営陣


䌚瀟名
䌚瀟名/ポゞション
ポゞション
株匏保有
倉動額
Ms. Kristin C. Peck
Ms. Kristin C. Peck
Chief Executive Officer, Director
Chief Executive Officer, Director
95.01K
+0.02%
Mr. Michael B. Mccallister
Mr. Michael B. Mccallister
Non-Executive Independent Chairman of the Board
Non-Executive Independent Chairman of the Board
25.86K
-6.61%
Mr. Gregory (Greg) Norden
Mr. Gregory (Greg) Norden
Independent Director
Independent Director
16.95K
+12.20%
Ms. Louise M. Parent
Ms. Louise M. Parent
Independent Director
Independent Director
15.26K
--
Mr. Frank A. D'amelio
Mr. Frank A. D'amelio
Independent Director
Independent Director
14.81K
--
Mr. Sanjay Khosla
Mr. Sanjay Khosla
Independent Director
Independent Director
9.81K
--
Dr. Robert J. (Rob) Polzer, Ph.D.
Dr. Robert J. (Rob) Polzer, Ph.D.
Executive Vice President, President - Research and Development
Executive Vice President, President - Research and Development
6.19K
+0.39%
Ms. Rimma Driscoll
Ms. Rimma Driscoll
Executive Vice President and Head of Global Strategy, Commercial and Business Development, and Global BioDevices
Executive Vice President and Head of Global Strategy, Commercial and Business Development, and Global BioDevices
5.19K
+8.28%
Ms. Vanessa Broadhurst
Ms. Vanessa Broadhurst
Independent Director
Independent Director
2.82K
+51.75%
Mr. Jamie Brannan
Mr. Jamie Brannan
Executive Vice President, Chief Commercial Officer
Executive Vice President, Chief Commercial Officer
2.59K
+19.25%
詳现を芋る
䌚瀟名
䌚瀟名/ポゞション
ポゞション
株匏保有
倉動額
Ms. Kristin C. Peck
Ms. Kristin C. Peck
Chief Executive Officer, Director
Chief Executive Officer, Director
95.01K
+0.02%
Mr. Michael B. Mccallister
Mr. Michael B. Mccallister
Non-Executive Independent Chairman of the Board
Non-Executive Independent Chairman of the Board
25.86K
-6.61%
Mr. Gregory (Greg) Norden
Mr. Gregory (Greg) Norden
Independent Director
Independent Director
16.95K
+12.20%
Ms. Louise M. Parent
Ms. Louise M. Parent
Independent Director
Independent Director
15.26K
--
Mr. Frank A. D'amelio
Mr. Frank A. D'amelio
Independent Director
Independent Director
14.81K
--
Mr. Sanjay Khosla
Mr. Sanjay Khosla
Independent Director
Independent Director
9.81K
--

収益内蚳

通貚: USD曎新時刻: Mon, Oct 6
通貚: USD曎新時刻: Mon, Oct 6
FY2025Q2
FY2025Q1
FY2024
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022
FY2022Q4
FY2022Q3
FY2022Q2
FY2022Q1
FY2021
FY2020
FY2019
事業別USD
䌚瀟名
収益
比率
Parasiticides
673.00M
27.36%
Vaccines
504.00M
20.49%
Dermatology
463.00M
18.82%
Anti-infectives
219.00M
8.90%
Pain and sedation
217.00M
8.82%
他の
384.00M
15.61%
地域別USD
䌚瀟名
収益
比率
United States
1.36B
55.12%
Other emerging markets
225.00M
9.15%
Other Developed
162.00M
6.59%
Brazil
93.00M
3.78%
Australia
83.00M
3.37%
他の
541.00M
21.99%
事業別
地域別
事業別USD
䌚瀟名
収益
比率
Parasiticides
673.00M
27.36%
Vaccines
504.00M
20.49%
Dermatology
463.00M
18.82%
Anti-infectives
219.00M
8.90%
Pain and sedation
217.00M
8.82%
他の
384.00M
15.61%

株䞻

曎新時刻: Sat, Nov 15
曎新時刻: Sat, Nov 15
株䞻統蚈
皮類
株䞻統蚈
株䞻統蚈
比率
The Vanguard Group, Inc.
9.55%
BlackRock Institutional Trust Company, N.A.
5.17%
State Street Investment Management (US)
4.46%
State Farm Insurance Companies
3.83%
Geode Capital Management, L.L.C.
2.53%
他の
74.46%
株䞻統蚈
株䞻統蚈
比率
The Vanguard Group, Inc.
9.55%
BlackRock Institutional Trust Company, N.A.
5.17%
State Street Investment Management (US)
4.46%
State Farm Insurance Companies
3.83%
Geode Capital Management, L.L.C.
2.53%
他の
74.46%
皮類
株䞻統蚈
比率
Investment Advisor
49.05%
Investment Advisor/Hedge Fund
32.09%
Research Firm
4.42%
Insurance Company
3.92%
Bank and Trust
2.62%
Pension Fund
2.55%
Hedge Fund
1.56%
Sovereign Wealth Fund
1.25%
Family Office
0.15%
他の
2.40%

機関投資家保有株


曎新時刻: Wed, Oct 1
曎新時刻: Wed, Oct 1
報告期間
機関投資家数
保有株匏数
比率
倉動額
2025Q3
3275
435.62M
98.29%
-1.39M
2025Q2
3277
434.35M
98.00%
-1.58M
2025Q1
3284
432.42M
97.12%
-4.21M
2024Q4
3199
430.60M
96.14%
-9.58M
2024Q3
3090
434.14M
95.81%
-13.19M
2024Q2
3062
437.75M
95.94%
-9.33M
2024Q1
3060
439.45M
96.16%
-2.63M
2023Q4
3074
438.13M
95.43%
-2.08M
2023Q3
2966
434.04M
94.28%
-3.00M
2023Q2
2949
430.67M
93.19%
-11.77M
詳现を芋る

株䞻動向


䌚瀟名
保有株匏数
比率
倉動額
倉動率
日付
The Vanguard Group, Inc.
41.69M
9.41%
+326.69K
+0.79%
Jun 30, 2025
BlackRock Institutional Trust Company, N.A.
22.66M
5.11%
-498.13K
-2.15%
Jun 30, 2025
State Street Investment Management (US)
19.74M
4.45%
-59.31K
-0.30%
Jun 30, 2025
State Farm Insurance Companies
16.84M
3.8%
-34.10K
-0.20%
Jun 30, 2025
Geode Capital Management, L.L.C.
11.08M
2.5%
+95.29K
+0.87%
Jun 30, 2025
Wellington Management Company, LLP
8.89M
2.01%
+2.82M
+46.56%
Jun 30, 2025
Polen Capital Management, LLC
8.42M
1.9%
-375.82K
-4.27%
Jun 30, 2025
Morgan Stanley Investment Management Ltd. (UK)
6.75M
1.52%
+4.58M
+209.96%
Jun 30, 2025
Wells Fargo Advisors
5.83M
1.32%
-180.38K
-3.00%
Jun 30, 2025
Norges Bank Investment Management (NBIM)
5.19M
1.17%
+131.36K
+2.60%
Jun 30, 2025
詳现を芋る

関連ETF


曎新時刻: Thu, Nov 6
曎新時刻: Thu, Nov 6
銘柄名
比率
ProShares Pet Care ETF
9.91%
VanEck Agribusiness ETF
7.63%
VanEck Pharmaceutical ETF
4.34%
iShares U.S. Pharmaceuticals ETF
4.32%
Honeytree US Equity ETF
3.92%
First Trust NASDAQ Pharmaceuticals ETF
3.43%
Polen Capital Global Growth ETF
3.35%
iShares ESG Aware MSCI USA Value ETF
3.19%
SPDR S&P Pharmaceuticals ETF
2.35%
Siren DIVCON Dividend Defender ETF
2.07%
詳现を芋る
ProShares Pet Care ETF
比率9.91%
VanEck Agribusiness ETF
比率7.63%
VanEck Pharmaceutical ETF
比率4.34%
iShares U.S. Pharmaceuticals ETF
比率4.32%
Honeytree US Equity ETF
比率3.92%
First Trust NASDAQ Pharmaceuticals ETF
比率3.43%
Polen Capital Global Growth ETF
比率3.35%
iShares ESG Aware MSCI USA Value ETF
比率3.19%
SPDR S&P Pharmaceuticals ETF
比率2.35%
Siren DIVCON Dividend Defender ETF
比率2.07%

配圓金


過去5幎間の配圓金総支払額は 2.94B 米ドルである。
日付
配圓金
暩利確定日
支払日
配圓萜ち日
Dec 12, 2024
ZTS.NB Interim Cash Dividend of gross USD 0.5 paid on Mar 04, 2025 going ex on Jan 21, 2025
Jan 21, 2025
Mar 04, 2025
Jan 21, 2025
Oct 10, 2024
ZTS.NB Final Cash Dividend of gross USD 0.432 paid on Dec 03, 2024 going ex on Oct 31, 2024
Oct 31, 2024
Dec 03, 2024
Oct 31, 2024
May 22, 2024
ZTS.NB Interim Cash Dividend of gross USD 0.432 paid on Sep 04, 2024 going ex on Jul 18, 2024
Jul 18, 2024
Sep 04, 2024
Jul 18, 2024
Feb 06, 2024
ZTS.NB Interim Cash Dividend of gross USD 0.432 paid on Jun 04, 2024 going ex on Apr 18, 2024
Apr 19, 2024
Jun 04, 2024
Apr 18, 2024
Dec 07, 2023
ZTS.NB Interim Cash Dividend of gross USD 0.432 paid on Mar 01, 2024 going ex on Jan 18, 2024
Jan 19, 2024
Mar 01, 2024
Jan 18, 2024
Oct 12, 2023
ZTS.NB Final Cash Dividend of gross USD 0.375 paid on Dec 01, 2023 going ex on Oct 31, 2023
Nov 01, 2023
Dec 01, 2023
Oct 31, 2023
May 11, 2023
ZTS.NB Interim Cash Dividend of gross USD 0.375 paid on Sep 01, 2023 going ex on Jul 20, 2023
Jul 21, 2023
Sep 01, 2023
Jul 20, 2023
Feb 08, 2023
ZTS.NB Interim Cash Dividend of gross USD 0.375 paid on Jun 01, 2023 going ex on Apr 20, 2023
Apr 21, 2023
Jun 01, 2023
Apr 20, 2023
Dec 08, 2022
ZTS.NB Interim Cash Dividend of gross USD 0.375 paid on Mar 01, 2023 going ex on Jan 19, 2023
Jan 20, 2023
Mar 01, 2023
Jan 19, 2023
Oct 13, 2022
ZTS.NB Final Cash Dividend of gross USD 0.325 paid on Dec 01, 2022 going ex on Oct 31, 2022
Nov 01, 2022
Dec 01, 2022
Oct 31, 2022
詳现を芋る

株匏分割


日付
皮類
比率
デヌタなし
日付
皮類
比率
デヌタなし

よくある質問

Zoetis Incの䞊䜍5名の株䞻は誰ですか


Zoetis Incの䞊䜍5名の株䞻は以䞋のずおりです。
The Vanguard Group, Inc.は41.69M株を保有しおおり、これは党䜓の9.41%に盞圓したす。
BlackRock Institutional Trust Company, N.A.は22.66M株を保有しおおり、これは党䜓の5.11%に盞圓したす。
State Street Investment Management (US)は19.74M株を保有しおおり、これは党䜓の4.45%に盞圓したす。
State Farm Insurance Companiesは16.84M株を保有しおおり、これは党䜓の3.80%に盞圓したす。
Geode Capital Management, L.L.C.は11.08M株を保有しおおり、これは党䜓の2.50%に盞圓したす。

Zoetis Incの株䞻タむプ䞊䜍3皮は䜕ですか


Zoetis Incの株䞻タむプ䞊䜍3皮は、
The Vanguard Group, Inc.
BlackRock Institutional Trust Company, N.A.
State Street Investment Management (US)

Zoetis IncZTSの株匏を保有しおいる機関の数はいく぀ですか


2025Q3時点で、Zoetis Incの株匏を保有しおいる機関は3275瀟あり、保有株匏の総垂堎䟡倀は玄435.62Mで、党䜓の98.29%を占めおいたす。2025Q2ず比范しお、機関の持ち株は0.29%増加しおいたす。

Zoetis Incの最倧の収益源は䜕ですか


FY2025Q2においお、Parasiticides郚門がZoetis Incにずっお最倧の収益を生み出しおおり、その金額は673.00Mで、党収益の27.36%を占めおいたす。
KeyAI
î™